Result of FASTA (omim) for
pF1KE4564
FASTA searches a protein or DNA sequence data bank 36.3.4 Apr, 2011
Please cite:
W.R. Pearson & D.J. Lipman PNAS (1988) 85:2444-2448
Query: pF1KE4564, 702 aa
1>>>pF1KE4564 702 - 702 aa - 702 aa
Library: /omim/omim.rfq.tfa
61127809 residues in 85815 sequences
Statistics: Expectation_n fit: rho(ln(x))= 8.3772+/-0.000525; mu= 4.0403+/- 0.033
mean_var=251.6431+/-53.988, 0's: 0 Z-trim(112.8): 330 B-trim: 1035 in 2/58
Lambda= 0.080850
statistics sampled from 21525 (21999) to 21525 sequences
Algorithm: FASTA (3.7 Nov 2010) [optimized]
Parameters: BL50 matrix (15:-5), open/ext: -10/-2
ktup: 2, E-join: 1 (0.584), E-opt: 0.2 (0.256), width: 16
Scan time: 10.950
The best scores are: opt bits E(85815)
NP_001278413 (OMIM: 114890) carcinoembryonic antig ( 702) 4700 563.1 1.4e-159
NP_004354 (OMIM: 114890) carcinoembryonic antigen- ( 702) 4700 563.1 1.4e-159
NP_001295327 (OMIM: 114890) carcinoembryonic antig ( 701) 4683 561.1 5.3e-159
XP_016881634 (OMIM: 114890) PREDICTED: carcinoembr ( 701) 4683 561.1 5.3e-159
XP_005258470 (OMIM: 114890) PREDICTED: carcinoembr ( 524) 3367 407.4 7.1e-113
XP_011524624 (OMIM: 114890) PREDICTED: carcinoembr ( 524) 2801 341.4 5.3e-93
XP_016881635 (OMIM: 114890) PREDICTED: carcinoembr ( 617) 2638 322.5 3.1e-87
NP_001703 (OMIM: 109770) carcinoembryonic antigen- ( 526) 2047 253.5 1.6e-66
NP_001020083 (OMIM: 109770) carcinoembryonic antig ( 464) 2041 252.7 2.4e-66
NP_001192273 (OMIM: 109770) carcinoembryonic antig ( 468) 2041 252.7 2.4e-66
NP_002474 (OMIM: 163980) carcinoembryonic antigen- ( 344) 1834 228.4 3.6e-59
XP_011525292 (OMIM: 163980) PREDICTED: carcinoembr ( 324) 1828 227.7 5.6e-59
XP_011525508 (OMIM: 109770) PREDICTED: carcinoembr ( 351) 1809 225.5 2.7e-58
NP_001171745 (OMIM: 109770) carcinoembryonic antig ( 368) 1803 224.8 4.6e-58
NP_001171742 (OMIM: 109770) carcinoembryonic antig ( 430) 1803 224.9 5.1e-58
NP_001171744 (OMIM: 109770) carcinoembryonic antig ( 461) 1803 224.9 5.4e-58
XP_016881683 (OMIM: 615747) PREDICTED: carcinoembr ( 368) 1620 203.5 1.2e-51
XP_011524642 (OMIM: 615747) PREDICTED: carcinoembr ( 415) 1620 203.5 1.3e-51
XP_016881685 (OMIM: 615747) PREDICTED: carcinoembr ( 331) 1615 202.9 1.7e-51
XP_016881684 (OMIM: 615747) PREDICTED: carcinoembr ( 349) 1612 202.5 2.3e-51
NP_001807 (OMIM: 615747) carcinoembryonic antigen- ( 349) 1612 202.5 2.3e-51
XP_011524643 (OMIM: 615747) PREDICTED: carcinoembr ( 255) 1202 154.6 4.5e-37
XP_016881687 (OMIM: 615747) PREDICTED: carcinoembr ( 255) 1202 154.6 4.5e-37
XP_011524644 (OMIM: 615747) PREDICTED: carcinoembr ( 255) 1202 154.6 4.5e-37
NP_001288637 (OMIM: 176398) pregnancy-specific bet ( 333) 1192 153.5 1.2e-36
XP_005259132 (OMIM: 176398) PREDICTED: pregnancy-s ( 402) 1192 153.6 1.4e-36
XP_011525428 (OMIM: 176392) PREDICTED: pregnancy-s ( 357) 1176 151.7 4.7e-36
NP_002776 (OMIM: 176401) pregnancy-specific beta-1 ( 335) 1170 151.0 7.3e-36
XP_016882494 (OMIM: 176398) PREDICTED: pregnancy-s ( 402) 1155 149.3 2.8e-35
XP_016882491 (OMIM: 176393) PREDICTED: pregnancy-s ( 333) 1144 147.9 5.9e-35
XP_016882488 (OMIM: 176393) PREDICTED: pregnancy-s ( 349) 1089 141.5 5.2e-33
XP_016881686 (OMIM: 615747) PREDICTED: carcinoembr ( 295) 943 124.4 6.2e-28
XP_011525429 (OMIM: 176392) PREDICTED: pregnancy-s ( 272) 858 114.5 5.7e-25
NP_001264092 (OMIM: 609142) carcinoembryonic antig ( 212) 813 109.1 1.8e-23
NP_001806 (OMIM: 609142) carcinoembryonic antigen- ( 252) 813 109.2 2.1e-23
NP_001284702 (OMIM: 176390) pregnancy-specific bet ( 428) 785 106.2 2.8e-22
NP_066296 (OMIM: 176392) pregnancy-specific beta-1 ( 428) 784 106.0 3.1e-22
NP_001171755 (OMIM: 176390) pregnancy-specific bet ( 417) 778 105.3 4.9e-22
NP_008836 (OMIM: 176390) pregnancy-specific beta-1 ( 426) 777 105.2 5.4e-22
NP_001171754 (OMIM: 176390) pregnancy-specific bet ( 419) 775 105.0 6.3e-22
NP_001303268 (OMIM: 176393) pregnancy-specific bet ( 297) 771 104.4 6.9e-22
NP_002774 (OMIM: 176396) putative pregnancy-specif ( 419) 773 104.8 7.4e-22
NP_001193579 (OMIM: 176396) putative pregnancy-spe ( 297) 766 103.8 1e-21
XP_016882486 (OMIM: 176393) PREDICTED: pregnancy-s ( 426) 768 104.2 1.1e-21
XP_016882484 (OMIM: 176393) PREDICTED: pregnancy-s ( 442) 768 104.2 1.1e-21
NP_001123640 (OMIM: 176397) pregnancy-specific bet ( 297) 764 103.5 1.2e-21
NP_002771 (OMIM: 176393) pregnancy-specific beta-1 ( 419) 766 103.9 1.3e-21
XP_016882485 (OMIM: 176393) PREDICTED: pregnancy-s ( 435) 766 104.0 1.3e-21
XP_011525289 (OMIM: 176397) PREDICTED: pregnancy-s ( 306) 761 103.2 1.6e-21
NP_874366 (OMIM: 176397) pregnancy-specific beta-1 ( 426) 762 103.5 1.8e-21
>>NP_001278413 (OMIM: 114890) carcinoembryonic antigen-r (702 aa)
initn: 4700 init1: 4700 opt: 4700 Z-score: 2986.3 bits: 563.1 E(85815): 1.4e-159
Smith-Waterman score: 4700; 99.9% identity (100.0% similar) in 702 aa overlap (1-702:1-702)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
:::::::::::::::::::::::::::::.::::::::::::::::::::::::::::::
NP_001 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
250 260 270 280 290 300
310 320 330 340 350 360
pF1KE4 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
310 320 330 340 350 360
370 380 390 400 410 420
pF1KE4 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
370 380 390 400 410 420
430 440 450 460 470 480
pF1KE4 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
430 440 450 460 470 480
490 500 510 520 530 540
pF1KE4 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
490 500 510 520 530 540
550 560 570 580 590 600
pF1KE4 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
550 560 570 580 590 600
610 620 630 640 650 660
pF1KE4 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
610 620 630 640 650 660
670 680 690 700
pF1KE4 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
::::::::::::::::::::::::::::::::::::::::::
NP_001 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
670 680 690 700
>>NP_004354 (OMIM: 114890) carcinoembryonic antigen-rela (702 aa)
initn: 4700 init1: 4700 opt: 4700 Z-score: 2986.3 bits: 563.1 E(85815): 1.4e-159
Smith-Waterman score: 4700; 99.9% identity (100.0% similar) in 702 aa overlap (1-702:1-702)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
:::::::::::::::::::::::::::::.::::::::::::::::::::::::::::::
NP_004 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
250 260 270 280 290 300
310 320 330 340 350 360
pF1KE4 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
310 320 330 340 350 360
370 380 390 400 410 420
pF1KE4 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
370 380 390 400 410 420
430 440 450 460 470 480
pF1KE4 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
430 440 450 460 470 480
490 500 510 520 530 540
pF1KE4 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
490 500 510 520 530 540
550 560 570 580 590 600
pF1KE4 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
550 560 570 580 590 600
610 620 630 640 650 660
pF1KE4 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
610 620 630 640 650 660
670 680 690 700
pF1KE4 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
::::::::::::::::::::::::::::::::::::::::::
NP_004 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
670 680 690 700
>>NP_001295327 (OMIM: 114890) carcinoembryonic antigen-r (701 aa)
initn: 2547 init1: 2547 opt: 4683 Z-score: 2975.6 bits: 561.1 E(85815): 5.3e-159
Smith-Waterman score: 4683; 99.7% identity (99.9% similar) in 702 aa overlap (1-702:1-701)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
:::::::::::::::::::::::::::::.::::::::::::::::::::::::::::::
NP_001 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
250 260 270 280 290 300
310 320 330 340 350 360
pF1KE4 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
::::::::::::::::::: ::::::::::::::::::::::::::::::::::::::::
NP_001 AHNSDTGLNRTTVTTITVY-EPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
310 320 330 340 350
370 380 390 400 410 420
pF1KE4 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
360 370 380 390 400 410
430 440 450 460 470 480
pF1KE4 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
420 430 440 450 460 470
490 500 510 520 530 540
pF1KE4 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
480 490 500 510 520 530
550 560 570 580 590 600
pF1KE4 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
540 550 560 570 580 590
610 620 630 640 650 660
pF1KE4 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
600 610 620 630 640 650
670 680 690 700
pF1KE4 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
::::::::::::::::::::::::::::::::::::::::::
NP_001 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
660 670 680 690 700
>>XP_016881634 (OMIM: 114890) PREDICTED: carcinoembryoni (701 aa)
initn: 2547 init1: 2547 opt: 4683 Z-score: 2975.6 bits: 561.1 E(85815): 5.3e-159
Smith-Waterman score: 4683; 99.7% identity (99.9% similar) in 702 aa overlap (1-702:1-701)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
:::::::::::::::::::::::::::::.::::::::::::::::::::::::::::::
XP_016 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
250 260 270 280 290 300
310 320 330 340 350 360
pF1KE4 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
::::::::::::::::::: ::::::::::::::::::::::::::::::::::::::::
XP_016 AHNSDTGLNRTTVTTITVY-EPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
310 320 330 340 350
370 380 390 400 410 420
pF1KE4 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
360 370 380 390 400 410
430 440 450 460 470 480
pF1KE4 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
420 430 440 450 460 470
490 500 510 520 530 540
pF1KE4 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
480 490 500 510 520 530
550 560 570 580 590 600
pF1KE4 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
540 550 560 570 580 590
610 620 630 640 650 660
pF1KE4 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
600 610 620 630 640 650
670 680 690 700
pF1KE4 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
::::::::::::::::::::::::::::::::::::::::::
XP_016 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
660 670 680 690 700
>>XP_005258470 (OMIM: 114890) PREDICTED: carcinoembryoni (524 aa)
initn: 3354 init1: 3354 opt: 3367 Z-score: 2147.5 bits: 407.4 E(85815): 7.1e-113
Smith-Waterman score: 3367; 97.8% identity (99.2% similar) in 510 aa overlap (1-510:1-510)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
:::::::::::::::::::::::::::::.::::::::::::::::::::::::::::::
XP_005 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
250 260 270 280 290 300
310 320 330 340 350 360
pF1KE4 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
310 320 330 340 350 360
370 380 390 400 410 420
pF1KE4 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
370 380 390 400 410 420
430 440 450 460 470 480
pF1KE4 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
430 440 450 460 470 480
490 500 510 520 530 540
pF1KE4 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
:::::::::::::::::: .:..:.. .
XP_005 NSASGHSRTTVKTITVSASGTSPGLSAGATVGIMIGVLVGVALI
490 500 510 520
>>XP_011524624 (OMIM: 114890) PREDICTED: carcinoembryoni (524 aa)
initn: 2788 init1: 2788 opt: 2801 Z-score: 1790.7 bits: 341.4 E(85815): 5.3e-93
Smith-Waterman score: 3134; 74.5% identity (74.6% similar) in 702 aa overlap (1-702:1-524)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
:::::::::::::::::::::::::::::.::::::::::::::::::::::::::::
XP_011 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPD--
190 200 210 220 230
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
XP_011 ------------------------------------------------------------
310 320 330 340 350 360
pF1KE4 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
XP_011 ------------------------------------------------------------
370 380 390 400 410 420
pF1KE4 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
::::
XP_011 --------------------------------------------------------DPTI
240
430 440 450 460 470 480
pF1KE4 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
250 260 270 280 290 300
490 500 510 520 530 540
pF1KE4 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
310 320 330 340 350 360
550 560 570 580 590 600
pF1KE4 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
370 380 390 400 410 420
610 620 630 640 650 660
pF1KE4 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
430 440 450 460 470 480
670 680 690 700
pF1KE4 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
::::::::::::::::::::::::::::::::::::::::::
XP_011 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
490 500 510 520
>>XP_016881635 (OMIM: 114890) PREDICTED: carcinoembryoni (617 aa)
initn: 2559 init1: 2559 opt: 2638 Z-score: 1687.1 bits: 322.5 E(85815): 3.1e-87
Smith-Waterman score: 3944; 87.6% identity (87.9% similar) in 702 aa overlap (1-702:1-617)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
:::::::::::::::::::::::::::::.::::::::::::::::::::::::
XP_016 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVL------
190 200 210 220 230
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
XP_016 ------------------------------------------------------------
310 320 330 340 350 360
pF1KE4 AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
.::::::::::::::::::::::::::::::::::::::::
XP_016 -------------------SEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
240 250 260 270
370 380 390 400 410 420
pF1KE4 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
280 290 300 310 320 330
430 440 450 460 470 480
pF1KE4 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
340 350 360 370 380 390
490 500 510 520 530 540
pF1KE4 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
400 410 420 430 440 450
550 560 570 580 590 600
pF1KE4 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
460 470 480 490 500 510
610 620 630 640 650 660
pF1KE4 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
520 530 540 550 560 570
670 680 690 700
pF1KE4 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
::::::::::::::::::::::::::::::::::::::::::
XP_016 ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI
580 590 600 610
>>NP_001703 (OMIM: 109770) carcinoembryonic antigen-rela (526 aa)
initn: 2363 init1: 1806 opt: 2047 Z-score: 1315.4 bits: 253.5 E(85815): 1.6e-66
Smith-Waterman score: 2047; 62.8% identity (79.3% similar) in 511 aa overlap (5-510:5-512)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::: :: .::: :::::::::::::::::.:: :: :::::::::::::::::::
NP_001 MGHLSAPLHRVRVPWQGLLLTASLLTFWNPPTTAQLTTESMPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
.::::::::::::::::::.::.::::::::::: :::: :::::::::::. :::::::
NP_001 QLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::.:::::::::::::::.:::::::::::::::.::::::::::::::::::.:::::.
NP_001 TLQVIKSDLVNEEATGQFHVYPELPKPSISSNNSNPVEDKDAVAFTCEPETQDTTYLWWI
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
::::::::::::::::::::::..:::::.. :.:: :::::: ::: : ::: ::::.:
NP_001 NNQSLPVSPRLQLSNGNRTLTLLSVTRNDTGPYECEIQNPVSANRSDPVTLNVTYGPDTP
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
:::: .: :: : ::.:::.:::::::::::..::::::::::::::::::::::::::.
NP_001 TISPSDTYYRPGANLSLSCYAASNPPAQYSWLINGTFQQSTQELFIPNITVNNSGSYTCH
250 260 270 280 290 300
310 320 330 340 350
pF1KE4 AHNSDTGLNRTTVTTITVYAEPP---KPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWW
:.:: :: ::::: :: : : :: : ..... . :.:.: ::: . . . :.
NP_001 ANNSVTGCNRTTVKTIIVTELSPVVAKPQIKASKTTVTGDKDSVNLTCSTNDTGISIRWF
310 320 330 340 350 360
360 370 380 390 400 410
pF1KE4 VNNQSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYG--P
.::::: : :..::. : ::.. : :.:.: : : . : .: ..:::..::: :. :
NP_001 FKNQSLPSSERMKLSQGNTTLSINPVKREDAGTYWCEVFNPISKNQSDPIMLNVNYNALP
370 380 390 400 410 420
420 430 440 450 460 470
pF1KE4 DDPTISPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLY
.. .::. :. ... .: : .: :. . ... ... . :.
NP_001 QENGLSPGAI---AGIVIGVVALVALIAVALACFLHFGKTGRASDQRDLTEHKPSVSNHT
430 440 450 460 470
480 490 500 510 520 530
pF1KE4 TCQANNSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWW
..:. . ...: .:.. :. : :.. :
NP_001 QDHSNDPPNKMNEVTYSTLNFEAQQPTQPTSASPSLTATEIIYSEVKKQ
480 490 500 510 520
540 550 560 570 580 590
pF1KE4 VNGQSLPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDT
>>NP_001020083 (OMIM: 109770) carcinoembryonic antigen-r (464 aa)
initn: 2363 init1: 1806 opt: 2041 Z-score: 1312.3 bits: 252.7 E(85815): 2.4e-66
Smith-Waterman score: 2041; 72.8% identity (85.6% similar) in 423 aa overlap (5-422:5-427)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::: :: .::: :::::::::::::::::.:: :: :::::::::::::::::::
NP_001 MGHLSAPLHRVRVPWQGLLLTASLLTFWNPPTTAQLTTESMPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
.::::::::::::::::::.::.::::::::::: :::: :::::::::::. :::::::
NP_001 QLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::.:::::::::::::::.:::::::::::::::.::::::::::::::::::.:::::.
NP_001 TLQVIKSDLVNEEATGQFHVYPELPKPSISSNNSNPVEDKDAVAFTCEPETQDTTYLWWI
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
::::::::::::::::::::::..:::::.. :.:: :::::: ::: : ::: ::::.:
NP_001 NNQSLPVSPRLQLSNGNRTLTLLSVTRNDTGPYECEIQNPVSANRSDPVTLNVTYGPDTP
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
:::: .: :: : ::.:::.:::::::::::..::::::::::::::::::::::::::.
NP_001 TISPSDTYYRPGANLSLSCYAASNPPAQYSWLINGTFQQSTQELFIPNITVNNSGSYTCH
250 260 270 280 290 300
310 320 330 340 350
pF1KE4 AHNSDTGLNRTTVTTITVYAEPP---KPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWW
:.:: :: ::::: :: : : :: : ..... . :.:.: ::: . . . :.
NP_001 ANNSVTGCNRTTVKTIIVTELSPVVAKPQIKASKTTVTGDKDSVNLTCSTNDTGISIRWF
310 320 330 340 350 360
360 370 380 390 400 410
pF1KE4 VNNQSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYG--P
.::::: : :..::. : ::.. : :.:.: : : . : .: ..:::..::: :. :
NP_001 FKNQSLPSSERMKLSQGNTTLSINPVKREDAGTYWCEVFNPISKNQSDPIMLNVNYNALP
370 380 390 400 410 420
420 430 440 450 460 470
pF1KE4 DDPTISPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLY
.. .::
NP_001 QENGLSPGAIAGIVIGVVALVALIAVALACFLHFGKTGSSGPLQ
430 440 450 460
>>NP_001192273 (OMIM: 109770) carcinoembryonic antigen-r (468 aa)
initn: 2363 init1: 1806 opt: 2041 Z-score: 1312.2 bits: 252.7 E(85815): 2.4e-66
Smith-Waterman score: 2041; 72.8% identity (85.6% similar) in 423 aa overlap (5-422:5-427)
10 20 30 40 50 60
pF1KE4 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
::: :: .::: :::::::::::::::::.:: :: :::::::::::::::::::
NP_001 MGHLSAPLHRVRVPWQGLLLTASLLTFWNPPTTAQLTTESMPFNVAEGKEVLLLVHNLPQ
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
.::::::::::::::::::.::.::::::::::: :::: :::::::::::. :::::::
NP_001 QLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFY
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
::.:::::::::::::::.:::::::::::::::.::::::::::::::::::.:::::.
NP_001 TLQVIKSDLVNEEATGQFHVYPELPKPSISSNNSNPVEDKDAVAFTCEPETQDTTYLWWI
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NNQSLPVSPRLQLSNGNRTLTLFNVTRNDSASYKCETQNPVSARRSDSVILNVLYGPDAP
::::::::::::::::::::::..:::::.. :.:: :::::: ::: : ::: ::::.:
NP_001 NNQSLPVSPRLQLSNGNRTLTLLSVTRNDTGPYECEIQNPVSANRSDPVTLNVTYGPDTP
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
:::: .: :: : ::.:::.:::::::::::..::::::::::::::::::::::::::.
NP_001 TISPSDTYYRPGANLSLSCYAASNPPAQYSWLINGTFQQSTQELFIPNITVNNSGSYTCH
250 260 270 280 290 300
310 320 330 340 350
pF1KE4 AHNSDTGLNRTTVTTITVYAEPP---KPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWW
:.:: :: ::::: :: : : :: : ..... . :.:.: ::: . . . :.
NP_001 ANNSVTGCNRTTVKTIIVTELSPVVAKPQIKASKTTVTGDKDSVNLTCSTNDTGISIRWF
310 320 330 340 350 360
360 370 380 390 400 410
pF1KE4 VNNQSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYG--P
.::::: : :..::. : ::.. : :.:.: : : . : .: ..:::..::: :. :
NP_001 FKNQSLPSSERMKLSQGNTTLSINPVKREDAGTYWCEVFNPISKNQSDPIMLNVNYNALP
370 380 390 400 410 420
420 430 440 450 460 470
pF1KE4 DDPTISPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLY
.. .::
NP_001 QENGLSPGAIAGIVIGVVALVALIAVALACFLHFGKTGRTTPMTHLTR
430 440 450 460
702 residues in 1 query sequences
61127809 residues in 85815 library sequences
Tcomplib [36.3.4 Apr, 2011] (8 proc)
start: Thu Jan 12 11:35:57 2017 done: Thu Jan 12 11:35:59 2017
Total Scan time: 10.950 Total Display time: 0.170
Function used was FASTA [36.3.4 Apr, 2011]